4//SEC Filing
Watson Robert Eugene 4
Accession 0001236215-21-000010
CIK 0000725363other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 5:34 PM ET
Size
5.6 KB
Accession
0001236215-21-000010
Insider Transaction Report
Form 4
CEL SCI CORPCVM
Watson Robert Eugene
Director
Transactions
- Award
Options
2021-05-14$0.01/sh+128,000$1,280→ 506,000 totalExercise: $20.61Exp: 2031-05-13→ Common Stock (128,000 underlying)
Footnotes (1)
- [F1]Each option entitles the holder to purchase one share of the Company's common stock at a price of $20.61 per share. The stock options vest 100% upon either (a) the filing of the first marketing application for any pharmaceutical based upon the Company's Multikine technology in any of the USA, Canada, UK, Germany, France, Italy, Spain, Japan, or Australia, or (b) if the closing price of the Company's common stock exceeds $42.00 for one trading day. None of the options will be exercisable before May 13, 2022.
Documents
Issuer
CEL SCI CORP
CIK 0000725363
Entity typeother
Related Parties
1- filerCIK 0001511858
Filing Metadata
- Form type
- 4
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 5:34 PM ET
- Size
- 5.6 KB